Laden...
MIT plan outlines new framework for expanding its international engagement.
Student teams develop technology-based tools to address racism and bias.
Termeer built Genzyme from a startup into a biotech powerhouse, while becoming an innovator in rare-disease drug development.
MechE class ends semester with ingeniously designed robots battling on a “Star Wars”-themed playing field.
Youssef Marzouk aims to improve predictions of everything from underground pollution to daily weather.
Information Systems and Technology staff is working with community members to secure devices against the Microsoft Windows-targeting system.
Xconomy reporter Ben Fidler writes about the life and legacy of Henri Termeer, a life member of the MIT Corporation who died at age 71. Institute Prof. Phillip Sharp explains that Termeer was, “a transformational leader in biotechnology of orphan diseases. Many children now have hope of a healthy life because of his vision and 40 years of creative business leadership.”
MIT was named one of “America’s Best Employers” in Forbes’ annual ranking of the top 500 workplaces around the country, reports CBS Boston.
Metro reporter Kristin Toussaint interviewed students in Course 2.007 as they tested robots they designed and built for the class’ annual robotics competition, which featured a “Star Wars” theme this year. “Every year we get crazy, cool, creative insights that the students come up with and awesome robots they build that we would have never anticipated,” explains Prof. Amos Winter.
CSAIL approach allows robots to learn a wider range of tasks using some basic knowledge and a single demo.
Electrochemical method can remove even tiny amounts of contamination.
Blocking the transition to a more aggressive state could offer a new treatment strategy.
Study at MIT Medical finds most parents are capable of performing the test.
Unsubscribe from our newsletter.
Have feedback or questions about our newsletter? Email [email protected]
This email was sent by: MIT News Office, 77 Massachusetts Avenue, Room 11-400, Cambridge, MA, 02139-4307, USA
© 2025